22951 results for "ega"

in 47.30 milliseconds.

• Exome sequence data from DNMT3A microcephalic dwarfism patients.

  Exome sequence data from microcephalic dwarfism patients with de novo DNMT3A variants

  Dataset EGAD00001004470

• HipSci - Macular Dystrophy - Exome Sequencing - July 2017

  HipSci - Macular Dystrophy - Exome Sequencing - July 2017

  Dataset EGAD00001003525

• RNA sequence of HUB_5 cell culture

  RNA sequence data for conditionally reprogrammed cells from patient HUB_5

  Dataset EGAD00001001923

• UK10K_NEURO_IOP_COLLIER REL-2013-04-20

  UK10K_NEURO_IOP_COLLIER REL-2013-04-20

  Dataset EGAD00001000442

• 11 plasma cases and 4 urine cases (mouse)

  11 plasma cases and 4 urine cases (mouse)

  Dataset EGAD00001009829

• Poly A transcriptom sequencing of mutifocal hepatocellular carcinoma

  Poly A transcriptome sequence of mutifocal hepatocelular carcinoma

  Dataset EGAD00001003231

• Myeloma Targeted Follow-up Study

  Targeted sequencing follow-up of genomic lesions in multiple myeloma.

  Dataset EGAD00001001215

• RNA-seq from normal human tissues

  RNA-seq from normal human tissues (2 x 250 bp)

  Dataset EGAD00001001922

• Heterogeneous Genomic Evolution and Immune Microenvironments in Metastatic Lung Cancer

  WES data of paired primary and metastatic tumors

  Dataset EGAD00001006213

• HIPO blastemal Wilms (nephroblastoma) exome sequencing samples

  HIPO blastemal Wilms (nephroblastoma) characterisation of tumor driving DNA alterations

  Dataset EGAD00001000995

• Whole genome sequencing of Crohn's disease patients

  Population based sequencing of whole genomes of Crohn's disease patients.

  Dataset EGAD00001000401

• GENCORD2_RNAseq

  GENCORD2 RNA-seq BAM files using BWA

  Dataset EGAD00001000425

• Carcinosarcoma Exome Sequencing Data

  Whole exome sequencing data from tumor and normal samples from carcinosarcoma (malignant mixed mullerian tumor) patients

  Dataset EGAD00001000987

• DATA FILES FOR PCGP SJINF WES

  DATA FILES FOR PCGP SJINF WES

  Dataset EGAD00001001245

• HipSci - Monogenic Diabetes - Exome Sequencing - April 2015

  HipSci - Monogenic Diabetes - Exome Sequencing - April 2015

  Dataset EGAD00001001949

• Gene expression from human iPSC derived motor neurons.

  Gene expression from human iPSC derived motor neurons.

  Dataset EGAD00001005216

• RNA-seq from melanoma biopsies

  RNA-seq data for melanoma biopsies at baseline and after treatment

  Dataset EGAD00001009059

• UK10K_RARE_SIR UK10K_EXOME_EXTRAS

  UK10K_RARE_SIR UK10K_EXOME_EXTRAS

  Dataset EGAD00001000757

• Whole Exome Sequencing

  Whole Exome Sequencing Data for 10 patients for treatment with the ICI Nivolumab

  Dataset EGAD00001011117

• Linked-reads for Juvenile Pilocytic Astrocytomas

  Matched tumor-normal data for 6 JPAs. Generated using 10X Genomics Linked-reads

  Dataset EGAD00001011114

• Osteosarcoma_X10

  This is a continuation of the osteosarcoma work we have undertaken.

  Study EGAS00001002167

• De_novo_mutations_in_schizophrenia_

  Project contains full exome data from 100-150 trios (up to 450 samples)

  Study EGAS00001000059

• Dyslipidemia

  These samples include exome sequences of family members with dyslipidemias from Finnish origin.

  Study EGAS00001000189

• mPAS- NXPE1 O-acetylation

  Paired-end fastq files from whole genome sequencing on Illumina HiSeq 4000 generated using bcl2fastq.

  Dataset EGAD00001015410

• Neuroblastoma sequencing data

  This study shares tumor and normal DNA for a patient with neuroblastoma

  Study EGAS00001005602

• Brain_Disease_Wellcome_Leap_Delta_Tissue_DNA

  Investigating how the tumour microenvironment regulates glioblastoma cell states using genomic analysis.

  Study EGAS00001005799

• Osteosarcoma sequencing data

  This study shares DNA and RNA sequencing data from embryonal rhadbomyosarcoma patients

  Study EGAS00001005600

• Somatic_mutation_in_edited_cholangiocyte_organoids_NanoSeq

  Characterisation of mutation rates and patterns in edited human cholangiocyte organoids (NanoSeq)

  Study EGAS00001006405

• Somatic_mutation_in_edited_cholangiocyte_organoids__Targeted_NanoSeq_

  Characterisation of mutation rates and patterns in edited human cholangiocyte organoids (Targeted NanoSeq)

  Study EGAS00001007266

• A non-canonical lymphoblast in refractory childhood T-cell leukaemia

  This dataset contains 75 WGS samples of T-ALL (including matched remission samples where available).

  Dataset EGAD00001015727

• iNHL WXS Data Commitee

  The iNHL WXS Data Commitee is responsible for managing access to datasets submitted to the European Genome-phenome Archive (EGA). Our committee ensures that access requests are evaluated in compliance with ethical guidelines, regulatory requirements, and the conditions specified by data submitters. Researchers requesting access to these datasets must provide a clear and valid scientific purpose, demonstrate affiliation with a recognized institution, and agree to the terms of use outlined in the Data Access Agreement. The iNHL WXS Data Commitee works to uphold data privacy and security while facilitating responsible data sharing to advance scientific discovery. For further information on our policies or the application process, please contact Hauke Busch (hauke.busch@uni-luebeck.de).

  Dac EGAC50000000488

• DFCI Gynecological Oncology Data Access Committee

  This Data Access Committee is responsible for reviewing requests to access controlled human genomic data generated as part of the RESOLVE clinical trial at DFCI. The committee ensures that access complies with participant consent, institutional policies, and applicable data protection regulations (e.g., GDPR). Data access decisions are made by a multidisciplinary panel including clinical researchers, bioinformaticians, and data governance officers from Dana-Farber Cancer Institute. The committee reviews each access request to determine whether the proposed research aligns with the study’s consent terms and the data access policy. If approved, access is granted via the European Genome-phenome Archive (EGA) in accordance with EGA’s data use and security guidelines.

  Dac EGAC50000000712

• Isolation of bacteria in infected brains in patients with Parkinsons disease. Here we used next generation sequencing of 16S ribosomal RNA gene PCR amplicons (NGS 16S amplicon analysis).

  Dac EGAC00001001197

• DAC for Combined MEK and BCL-2/XL inhibition is effective in high-grade serous ovarian cancer patient-derived xenograft models and BIM levels are predictive of responsiveness

  Dac EGAC00001001250